Cns Pharmaceuticals Inc (CNSP)

Finanzdaten der Cns Pharmaceuticals Inc-Aktie (CNSP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	45.73%2.70	4.98	5.99	3.25	2.41
Research and Development	66.11%1.20	3.54	3.17	2.20	1.17
Operating Income/Loss	45.73%-2.70	-4.98	-5.99	-3.25	-2.41
Nonoperating Income/Loss	193.51%0.11	0.04	0.03	0.03	0.03
	47.58%-2.59	-4.94	-5.96	-3.22	-2.37
Attributable To Parent	47.58%-2.59	-4.94	-5.96	-3.22	-2.37
Basic Average Shares	911.31%6.84	0.68	-	0.56	0.37
Diluted Average Shares	911.31%6.84	0.68	-	0.56	0.37
Basic Earnings Per Share	94.79%-0.38	-7.30	-	-5.76	-6.42
Diluted Earnings Per Share	94.79%-0.38	-7.30	-	-5.76	-6.42